Clinical trial
Early Prediction of Patient-related and Radiological Outcomes in Patients With Recent-onset Inflammatory Polyarthritis (EPA) Using Established and Novel Independent Predictors
NCT00512239 is registered in ClinicalTrials.gov with Gilles Boire as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Prediction of Patient-related and Radiological Outcomes in Patients With Recent-onset Inflammatory Polyarthritis (EPA) Using Established and Novel Independent Predictors
- Lead sponsor
- Gilles Boire
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- July 31, 1998
- Completion date
- December 31, 2035
- Enrollment
- 1,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
inflammatory arthritis, rheumatoid arthritis